Subjective effects of a proprietary Eurycoma longifolia and Polygonum minus combination on well-being and sexual performance in patients with mild erectile dysfunction: a randomized controlled trial

Biotropics Malaysia Berhad (Malaysia)0 个研究点目标入组 26 人开始时间: 2012年2月23日最近更新: 2016年10月17日

适应症

试验速览

暂无简介。

•1. Male subjects between the ages of 40 and 65 at the time of screening, and in a stable heterosexual relationship for at least six months. Both partners had to agree to attempt intercourse at least once a week on average during the study.
•2. Subjects with testosterone levels = 450ng/dL
•3. Index of erectile dysfunction scores between17-25

•1. Subjects with a history of prostate cancer, elevated prostate-specific antigen (PSA), benign prostate hypertrophy (BPH) scores = 40, penile anatomical abnormalities, premature ejaculation
•2. Cardiovascular disease, resting hypotension (resting systolic blood pressure <90mmHg) or hypertension (resting systolic blood pressure >170mmHg or diastolic pressure >110mmHg)
•3. Primary hypoactive sexual desire
•4. Seizures
•5. Hereditary degenerative retinal disorders or loss of vision
•6. Liver disease
•7. Clinically significant chronic hematological disease, bleeding disorders
•8. Significant active peptic ulceration
•9. Symptomatic postural hypotension or syncope within the previous six months
•10. Malignancy within the previous five years (other than squamous or basal cell)
•11. A positive test for hepatitis B surface antigen or hepatitis C
•12. Alcoholism (an alcohol screening score =2)
•13. Congenital spinal cord deformities or traumatic injuries, congenital or traumatic brain injuries
•13. An abnormal prostate exam during the screening visit

发起方